iEmoji Feeds @Annals of Oncology (Annals_Oncology)
1.
Annals of Oncology
@Annals_Oncology
The intestinal microbiome is associated with response to immune checkpoint inhibitors in patients with cancer.
Th… twitter.com/i/web/status/1…
Th… twitter.com/i/web/status/1…
2.
Annals of Oncology
@Annals_Oncology
Just out, a report from the ARCAGEN study of rare GI malignancies in the @EORTC - SPECTA molecular profiling prog… twitter.com/i/web/status/1…
3.
4.
5.
6.
7.
Annals of Oncology
@Annals_Oncology
In the May 2022 issue of @Annals_Oncology :
Precision medicine
@myESMO expert consensus statement & clinic… twitter.com/i/web/status/1…
Precision medicine
@myESMO expert consensus statement & clinic… twitter.com/i/web/status/1…
Annals of Oncology
@Annals_Oncology
The relentless quest for biomarkers predicting the outcome of immune-checkpoint blockade:
in press in Annals of O… twitter.com/i/web/status/1…
in press in Annals of O… twitter.com/i/web/status/1…
Annals of Oncology
@Annals_Oncology
Early detection could improve cure rates, mainly in cancers without screening modalities.
Just out in Annals of… twitter.com/i/web/status/1…
Just out in Annals of… twitter.com/i/web/status/1…
Annals of Oncology
@Annals_Oncology
When all meetings like @ASCO #ASCO21 are virtual what are the TOP 10 advances in cancer research dissemination thr… twitter.com/i/web/status/1…
Retweet of status by @VivekSubbiah
Annals of Oncology
@Annals_Oncology
Can a blood test🩸 replace mammograms for the screening of breast cancer? With #ESMOBreast21 around the corner, re… twitter.com/i/web/status/1…
8.
9.
10.
Annals of Oncology
@Annals_Oncology
Current landscape of clinical development:
Regulatory approval for mTNBC
Other pivotal studies in breast cancer:… twitter.com/i/web/status/1…
Regulatory approval for mTNBC
Other pivotal studies in breast cancer:… twitter.com/i/web/status/1…
Annals of Oncology
@Annals_Oncology
Just out in Annals of Oncology: European cancer mortality predictions for the year 2021 with focus on pancreatic a… twitter.com/i/web/status/1…
Annals of Oncology
@Annals_Oncology
#ESMO20: First new drug in years reduces recurrence in high-risk hormone receptor positive early #breastcancer … twitter.com/i/web/status/1…
...but wait! There's more!
1.
fakhright
@fakhright
astaghfirullah peng.krim guaaaaaaaa..............a *salto sambil solat*
